Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network.

COVID-19 TB TB infection management infection control migration prevention screening workplace safety

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
05 Nov 2021
Historique:
received: 01 10 2021
revised: 28 10 2021
accepted: 29 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Tuberculosis (TB) does not respect borders, and migration confounds global TB control and elimination. Systematic screening of immigrants from TB high burden settings and-to a lesser degree TB infection (TBI)-is recommended in most countries with a low incidence of TB. The aim of the study was to evaluate the views of a diverse group of international health professionals on TB management among migrants. Participants expressed their level of agreement using a six-point Likert scale with different statements in an online survey available in English, French, Mandarin, Spanish, Portuguese and Russian. The survey consisted of eight sections, covering TB and TBI screening and treatment in migrants. A total of 1055 respondents from 80 countries and territories participated between November 2019 and April 2020. The largest professional groups were pulmonologists (16.8%), other clinicians (30.4%), and nurses (11.8%). Participants generally supported infection control and TB surveillance established practices (administrative interventions, personal protection, etc.), while they disagreed on how to diagnose and manage both TB and TBI, particularly on which TBI regimens to use and when patients should be hospitalised. The results of this first knowledge, attitude and practice study on TB screening and treatment in migrants will inform public health policy and educational resources.

Identifiants

pubmed: 34827293
pii: antibiotics10111355
doi: 10.3390/antibiotics10111355
pmc: PMC8615134
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Eur Respir J. 2016 Sep;48(3):808-17
pubmed: 27492827
Radiology. 2017 Aug;284(2):574-582
pubmed: 28436741
Lancet. 2016 Nov 19;388(10059):2510-2518
pubmed: 27742165
Int J Infect Dis. 2019 Mar;80S:S45-S49
pubmed: 30826482
Int J Tuberc Lung Dis. 2020 May 1;24(5):21-26
pubmed: 32553039
Pneumonia (Nathan). 2020 Sep 5;12:9
pubmed: 32923311
Eur Respir Rev. 2019 May 29;28(152):
pubmed: 31142548
Lancet Infect Dis. 2018 Sep;18(9):e259-e271
pubmed: 29778396
Eur Respir J. 2018 Dec 6;52(6):
pubmed: 30309977
Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142
pubmed: 31729908
Eur Respir J. 2018 Jul 11;52(1):
pubmed: 29794133
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Int J Tuberc Lung Dis. 2021 Oct 1;25(10):797-813
pubmed: 34615577
J Bras Pneumol. 2017 Sep-Oct;43(5):380-392
pubmed: 29160384
Eur Respir J. 2014 May;43(5):1410-20
pubmed: 24389868
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637
pubmed: 28482956
Expert Rev Anti Infect Ther. 2013 Feb;11(2):137-46
pubmed: 23409820
MMWR Morb Mortal Wkly Rep. 2019 May 17;68(19):439-443
pubmed: 31099768
Eur Respir J. 2018 May 17;51(5):
pubmed: 29678945
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):321-323
pubmed: 33762077
PLoS One. 2014 Nov 13;9(11):e112681
pubmed: 25393241
Eur Respir J. 2019 Jun 5;53(6):
pubmed: 31023852
Eur Respir J. 2011 May;37(5):1175-82
pubmed: 21071474
Clin Infect Dis. 2018 Feb 10;66(5):706-711
pubmed: 29028965
Int J Tuberc Lung Dis. 2015 Feb;19(2):205-9
pubmed: 25574920
Clinicoecon Outcomes Res. 2016 Jun 30;8:335-47
pubmed: 27418848
Int J Tuberc Lung Dis. 2021 Nov 1;25(11):903-910
pubmed: 34686232
ERJ Open Res. 2018 Jul 13;4(3):
pubmed: 30018973
Eur Respir J. 2016 May;47(5):1345-7
pubmed: 27009169
BMC Med. 2016 Mar 23;14:48
pubmed: 27004556
Eur Respir Rev. 2018 Jun 13;27(148):
pubmed: 29898905
Int J Tuberc Lung Dis. 2018 Aug 1;22(8):835-843
pubmed: 29991390
Int J Infect Dis. 2020 Mar;92S:S15-S25
pubmed: 32032752
Lancet Infect Dis. 2017 Jul;17(7):770-779
pubmed: 28410979
Int J Tuberc Lung Dis. 2017 Jul 1;21(7):727-736
pubmed: 28633696
Euro Surveill. 2018 Apr;23(14):
pubmed: 29637889

Auteurs

Lia D'Ambrosio (L)

Public Health Consulting Group, 6900 Lugano, Switzerland.

Rosella Centis (R)

Servizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy.

Claudia C Dobler (CC)

The George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia.
Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW 2107, Australia.

Simon Tiberi (S)

Department of Infection, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Blizard Institute, Queen Mary University of London, London E1 2AT, UK.

Alberto Matteelli (A)

Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.
WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, 25123 Brescia, Italy.

Justin Denholm (J)

Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC 3000, Australia.
Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia.
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia.

Dominik Zenner (D)

Centre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London E1 2AB, UK.

Seif Al-Abri (S)

Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.

Fatma Alyaquobi (F)

Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.

Marcos Abdo Arbex (MA)

Nestor Goulart Reis Hospital, Health Secretary São Paulo State, Sao Paulo 14801-320, Brazil.
Faculdade de Medicina, Universidade de Araraquara, Sao Paulo 14801-320, Brazil.

Evgeny Belilovskiy (E)

Moscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.

François-Xavier Blanc (FX)

Service de Pneumologie, Centre Hospitalier Universitaire, L'institut du Thorax, F-44093 Nantes, France.

Sergey Borisov (S)

Moscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.

Anna Cristina C Carvalho (ACC)

Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil.

Jeremiah Muhwa Chakaya (JM)

Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi P.O. Box 43844-00100, Kenya.
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.

Nicola Cocco (N)

ASST Santi Paolo e Carlo-Medicina Penitenziaria, 21100 Milan, Italy.

Luigi Ruffo Codecasa (LR)

TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, 20159 Milan, Italy.

Margareth Pretti Dalcolmo (MP)

Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro 21040-360, Brazil.

Keertan Dheda (K)

South African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town 7701, South Africa.
Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town 7701, South Africa.
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London 400706, UK.

Anh Tuan Dinh-Xuan (AT)

Respiratory Physiology Unit, Department of Respiratory Medicine, Cochin Hospital, Université de Paris, 75014 Paris, France.

Susanna R Esposito (SR)

Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, 43126 Parma, Italy.

José-María García-García (JM)

Tuberculosis Research Programme SEPAR, E-08029 Barcelona, Spain.

Yang Li (Y)

Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China.

Selene Manga (S)

Ministry of Health, Direccion General de Gestion de Riesgos en y Desastres en Salud, Lima 15072, Peru.

Valentina Marchese (V)

Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.
WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, 25123 Brescia, Italy.

Marcela Muñoz Torrico (M)

Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.

Emanuele Pontali (E)

Department of Infectious Diseases, Galliera Hospital, 16128 Genoa, Italy.

Adrián Rendon (A)

Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey 64000, Mexico.

Denise Rossato Silva (D)

Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.

Rupak Singla (R)

Department of TB & Respiratory Diseases, National Institute of TB & Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India.

Ivan Solovic (I)

National Institute for TB, Vysne Hagy, Catholic University, 05984 Ruzomberok, Slovakia.

Giovanni Sotgiu (G)

Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.

Martin van den Boom (M)

WHO Regional Office for the Eastern Mediterranean Region, Cairo 11571, Egypt.

Nguyen Viet Nhung (NV)

National Tuberculosis Programme, Hanoi 100000, Vietnam.

Jean-Pierre Zellweger (JP)

TB Competence Center, Swiss Lung Association, 3030 Berne, Switzerland.

Giovanni Battista Migliori (GB)

Servizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy.

Classifications MeSH